|
Volumn 128, Issue 2, 2016, Pages 229-230
|
Hepatitis C Virus Screening in Pregnancy: Is It Time to Change Our Practice?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
DIAMORPHINE;
NARCOTIC AGENT;
OPIATE;
ANTIVIRAL THERAPY;
BLOOD TRANSFUSION;
CESAREAN SECTION;
CLINICAL ASSESSMENT;
CLINICAL PRACTICE;
DIAGNOSTIC TEST;
EDITORIAL;
HEPATITIS C;
HEPATITIS C VIRUS;
HIGH RISK PATIENT;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
MATERNAL DISEASE;
MEDICAL INFORMATION;
MORBIDITY;
OBSERVATIONAL STUDY;
OPIATE ADDICTION;
PATIENT CARE;
PRACTICE GUIDELINE;
PREGNANT WOMAN;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RISK FACTOR;
SCREENING TEST;
VERTICAL TRANSMISSION;
VIRUS STRAIN;
FEMALE;
HEPACIVIRUS;
HEPATITIS B;
MASS SCREENING;
PREGNANCY;
PREGNANCY COMPLICATION;
FEMALE;
HEPACIVIRUS;
HEPATITIS B;
HEPATITIS C;
HUMANS;
MASS SCREENING;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
|
EID: 84978085733
PISSN: 00297844
EISSN: 1873233X
Source Type: Journal
DOI: 10.1097/AOG.0000000000001536 Document Type: Editorial |
Times cited : (9)
|
References (7)
|